These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 22006018)
21. D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. Kovoor A; Seyffarth P; Ebert J; Barghshoon S; Chen CK; Schwarz S; Axelrod JD; Cheyette BN; Simon MI; Lester HA; Schwarz J J Neurosci; 2005 Feb; 25(8):2157-65. PubMed ID: 15728856 [TBL] [Abstract][Full Text] [Related]
22. Differential regulation of somatostatin receptor dephosphorylation by β-arrestin1 and β-arrestin2. Kliewer A; Schulz S Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar; 387(3):263-9. PubMed ID: 24276218 [TBL] [Abstract][Full Text] [Related]
23. The conformational signature of β-arrestin2 predicts its trafficking and signalling functions. Lee MH; Appleton KM; Strungs EG; Kwon JY; Morinelli TA; Peterson YK; Laporte SA; Luttrell LM Nature; 2016 Mar; 531(7596):665-8. PubMed ID: 27007854 [TBL] [Abstract][Full Text] [Related]
24. Postnatal induction and localization of R7BP, a membrane-anchoring protein for regulator of G protein signaling 7 family-Gbeta5 complexes in brain. Grabowska D; Jayaraman M; Kaltenbronn KM; Sandiford SL; Wang Q; Jenkins S; Slepak VZ; Smith Y; Blumer KJ Neuroscience; 2008 Feb; 151(4):969-82. PubMed ID: 18248908 [TBL] [Abstract][Full Text] [Related]
25. Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent Signaling pathways. Nakaya M; Chikura S; Watari K; Mizuno N; Mochinaga K; Mangmool S; Koyanagi S; Ohdo S; Sato Y; Ide T; Nishida M; Kurose H J Biol Chem; 2012 Oct; 287(42):35669-35677. PubMed ID: 22888001 [TBL] [Abstract][Full Text] [Related]
26. RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors. Celver J; Sharma M; Kovoor A J Neurochem; 2010 Aug; 114(3):739-49. PubMed ID: 20477943 [TBL] [Abstract][Full Text] [Related]
27. Expression and localization of RGS9-2/G 5/R7BP complex in vivo is set by dynamic control of its constitutive degradation by cellular cysteine proteases. Anderson GR; Lujan R; Semenov A; Pravetoni M; Posokhova EN; Song JH; Uversky V; Chen CK; Wickman K; Martemyanov KA J Neurosci; 2007 Dec; 27(51):14117-27. PubMed ID: 18094251 [TBL] [Abstract][Full Text] [Related]
28. PKCβII inhibits the ubiquitination of β-arrestin2 in an autophosphorylation-dependent manner. Zheng M; Zhang X; Guo S; Zhang X; Choi HJ; Lee MY; Kim KM FEBS Lett; 2015 Dec; 589(24 Pt B):3929-37. PubMed ID: 26545496 [TBL] [Abstract][Full Text] [Related]
29. The Gbeta5-RGS7 complex selectively inhibits muscarinic M3 receptor signaling via the interaction between the third intracellular loop of the receptor and the DEP domain of RGS7. Sandiford SL; Slepak VZ Biochemistry; 2009 Mar; 48(10):2282-9. PubMed ID: 19182865 [TBL] [Abstract][Full Text] [Related]
30. G protein beta 5 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalization. Octeau JC; Schrader JM; Masuho I; Sharma M; Aiudi C; Chen CK; Kovoor A; Celver J PLoS One; 2014; 9(8):e105791. PubMed ID: 25162404 [TBL] [Abstract][Full Text] [Related]
31. β-Arrestins and G protein-coupled receptor trafficking. Kang DS; Tian X; Benovic JL Methods Enzymol; 2013; 521():91-108. PubMed ID: 23351735 [TBL] [Abstract][Full Text] [Related]
32. Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins. Tóth AD; Prokop S; Gyombolai P; Várnai P; Balla A; Gurevich VV; Hunyady L; Turu G J Biol Chem; 2018 Jan; 293(3):876-892. PubMed ID: 29146594 [TBL] [Abstract][Full Text] [Related]
33. Differential and competitive regulation of human melanocortin 1 receptor signaling by β-arrestin isoforms. Abrisqueta M; Herraiz C; Pérez Oliva AB; Sanchez-Laorden BL; Olivares C; Jiménez-Cervantes C; García-Borrón JC J Cell Sci; 2013 Aug; 126(Pt 16):3724-37. PubMed ID: 23750009 [TBL] [Abstract][Full Text] [Related]
34. Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors. Cho D; Zheng M; Min C; Ma L; Kurose H; Park JH; Kim KM Mol Endocrinol; 2010 Mar; 24(3):574-86. PubMed ID: 20160122 [TBL] [Abstract][Full Text] [Related]
35. Multiple signaling routes involved in the regulation of adenylyl cyclase and extracellular regulated kinase by dopamine D(2) and D(3) receptors. Jin M; Min C; Zheng M; Cho DI; Cheong SJ; Kurose H; Kim KM Pharmacol Res; 2013 Jan; 67(1):31-41. PubMed ID: 23059541 [TBL] [Abstract][Full Text] [Related]
36. D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions. Celver J; Sharma M; Kovoor A J Neurochem; 2012 Jan; 120(1):56-69. PubMed ID: 22035199 [TBL] [Abstract][Full Text] [Related]
37. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Gao H; Sun Y; Wu Y; Luan B; Wang Y; Qu B; Pei G Mol Cell; 2004 May; 14(3):303-17. PubMed ID: 15125834 [TBL] [Abstract][Full Text] [Related]
38. High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay. Hamdan FF; Audet M; Garneau P; Pelletier J; Bouvier M J Biomol Screen; 2005 Aug; 10(5):463-75. PubMed ID: 16093556 [TBL] [Abstract][Full Text] [Related]
39. Specific interactions between Epac1, β-arrestin2 and PDE4D5 regulate β-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling. Berthouze-Duquesnes M; Lucas A; Saulière A; Sin YY; Laurent AC; Galés C; Baillie G; Lezoualc'h F Cell Signal; 2013 Apr; 25(4):970-80. PubMed ID: 23266473 [TBL] [Abstract][Full Text] [Related]
40. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization. Fessart D; Simaan M; Laporte SA Mol Endocrinol; 2005 Feb; 19(2):491-503. PubMed ID: 15498833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]